According to a post on the FDA’s website, Ionis Pharmaceuticals’ treatment of Pelizaeus-Merzbacher disease was granted orphan designation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IONS: